BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24332490)

  • 1. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
    Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
    Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-breast cancer activity of heteroaryl chalcone derivatives.
    Solomon VR; Lee H
    Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.
    Gu X; Ren Z; Tang X; Peng H; Ma Y; Lai Y; Peng S; Zhang Y
    Bioorg Med Chem; 2012 Apr; 20(8):2540-8. PubMed ID: 22429509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and
    Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
    Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
    Jin GZ; Jin HS; Jin LL
    Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
    Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
    Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
    Teng CH; Won SJ; Lin CN
    Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
    Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
    Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
    Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
    Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
    Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
    Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
    Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of aromatic enones related to curcumin.
    Robinson TP; Hubbard RB; Ehlers TJ; Arbiser JL; Goldsmith DJ; Bowen JP
    Bioorg Med Chem; 2005 Jun; 13(12):4007-13. PubMed ID: 15911313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
    Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
    Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and anticancer activity of nitric oxide donating/chalcone hybrids.
    Mourad MA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH
    Eur J Med Chem; 2012 Aug; 54():907-13. PubMed ID: 22703846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.
    Lee HW; Cho CS; Kang SK; Yoo YS; Shin JS; Ahn SK
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1024-9. PubMed ID: 17603194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents.
    Zhang H; Liu JJ; Sun J; Yang XH; Zhao TT; Lu X; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 May; 20(10):3212-8. PubMed ID: 22503741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel isoflavene-propranolol hybrids as anti-tumor agents.
    Yee EM; Pasquier E; Iskander G; Wood K; Black DS; Kumar N
    Bioorg Med Chem; 2013 Apr; 21(7):1652-60. PubMed ID: 23462711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, electrochemical studies and antitumor activity of some new chalcone analogues containing ferrocenyl pyrazole moiety.
    Ratković Z; Juranić ZD; Stanojković T; Manojlović D; Vukićević RD; Radulović N; Joksović MD
    Bioorg Chem; 2010 Feb; 38(1):26-32. PubMed ID: 19846191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of imidazothiazole-chalcone derivatives as anticancer and apoptosis inducing agents.
    Kamal A; Dastagiri D; Ramaiah MJ; Reddy JS; Bharathi EV; Srinivas C; Pushpavalli SN; Pal D; Pal-Bhadra M
    ChemMedChem; 2010 Nov; 5(11):1937-47. PubMed ID: 20836120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4.
    Kerr DJ; Hamel E; Jung MK; Flynn BL
    Bioorg Med Chem; 2007 May; 15(9):3290-8. PubMed ID: 17360188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.